VYNE Therapeutics Inc. (VYNE) Yarrow Bioscience, Inc. - M&A Call Prepared Remarks Transcript [Seeking Alpha]
VYNE Therapeutics Inc. (VYNE)
Company Research
Source: Seeking Alpha
David Domzalski - CEO, President & Director Rebecca Frey Conference Call Participants John Fraunces - Lifesci Advisors, LLC Presentation Operator Good morning, and welcome to the VYNE Therapeutics conference call to discuss the merger of VYNE and Yarrow Bioscience. This call is being recorded for replay at the company's request. It's now my pleasure to turn the call over to John Fraunces, Director, Corporate Communications for LifeSci Advisors. Please go ahead, John. John Fraunces Lifesci Advisors, LLC Good morning, and thank you for joining us for today's conference call. The link to this webcast is on the Investors page of the VYNE Therapeutics corporate website. Before we begin, I would like to remind you that our call today will include remarks about future expectations, plans and prospects for VYNE and Yarrow, which constitute forward-looking statements for the purpose of the safe harbor provisions under applicable federal securities laws. These forward-loo
Show less
Read more
Impact Snapshot
Event Time:
VYNE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VYNE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VYNE alerts
High impacting VYNE Therapeutics Inc. news events
Weekly update
A roundup of the hottest topics
VYNE
News
- VYNE Stock Alert: Halper Sadeh LLC is Investigating Whether the Merger of VYNE Therapeutics Inc. is Fair to ShareholdersBusiness Wire
- VYNE Therapeutics and Yarrow Bioscience Announce Merger Agreement [Yahoo! Finance]Yahoo! Finance
- VYNE Therapeutics and Yarrow Bioscience Announce Merger Agreement GlobeNewswire
- Vitiligo Pipeline Market Report 2025: Comprehensive Insights About 18+ Companies and 20+ Pipeline Drugs - Emerging Therapies Like JAK Inhibitors Show Promise, Enhancing Treatment Options [Yahoo! Finance]Yahoo! Finance
- VYNE Therapeutics Reports 2025 Third Quarter Financial Results and Provides Business UpdateGlobeNewswire
VYNE
Sec Filings
- 12/17/25 - Form 425
- 12/17/25 - Form 8-K
- 12/15/25 - Form 4
- VYNE's page on the SEC website